Skip to content
ClinCalc Pro
Menu
Osmotic bowel cleanser

Macrogol 3350 with sulfate, ascorbate, KCl & NaCl (bowel prep)

Brand names: Moviprep, Plenvu

This combination of macrogol 3350 with sodium sulfate, ascorbic acid, sodium ascorbate, potassium chloride and sodium chloride is an oral bowel-cleansing preparation used before colonoscopy, bowel surgery or radiological imaging.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

The macrogol and sodium sulfate act as osmotic agents that draw large volumes of water into the colon to produce a watery purge, while the ascorbate component contributes additional osmotic effect, together evacuating the bowel without significant net absorption.

Prescribing in practice

  • Bowel-cleansing solutions can cause clinically significant dehydration and electrolyte disturbance, so they are contraindicated in gut obstruction or perforation, ileus, toxic colitis and severe dehydration, and used with caution in frail, elderly, renally or cardiac-impaired patients.
  • Adequate intake of clear fluids alongside the preparation is essential, and the ascorbic acid content makes it unsuitable for patients with glucose-6-phosphate dehydrogenase deficiency.
  • Oral medicines taken around the time of the purge may be incompletely absorbed, so the timing of essential drugs should be reviewed.

Monitoring

Assess hydration, renal function and electrolytes before and, where indicated, after administration in patients at risk of fluid or electrolyte depletion.

Counselling the patient

  • Follow the split-dose timing exactly and drink plenty of the recommended clear fluids to avoid dehydration.
  • Expect frequent watery stools; stay near a toilet once you start.
  • Report dizziness, palpitations, severe abdominal pain or persistent vomiting promptly.

Evidence & guidelines

Low-volume macrogol-ascorbate bowel preparations are widely used in UK endoscopy services as an effective alternative to standard-volume regimens, with MHRA advice emphasising hydration and electrolyte safety.

Reference: NICE CG118; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.